Insider Transactions Reported by 19 Insiders of Ensysce Biosciences, Inc.

Symbol
ENSC on Nasdaq, ENSCW on OTC
Location
La Jolla, CA

There are no Buy or Sell transactions made by insiders since 09 Mar 2025

Ensysce Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
A. LORNE WEIL 10%+ Owner $1,868,005 30 Jun 2021
Daniel B. Silvers 10%+ Owner $1,754,497 30 Jun 2021
William H. Chang Director, 10%+ Owner $1,267,451 23 Jun 2022
BOB G. GOWER Director $597,036 02 Mar 2023
Lynn Kirkpatrick Chief Executive Officer, Director $186,458 25 May 2022
Eric Carrera Former officer $30,000 30 Jun 2021
George Peng Former officer $15,000 30 Jun 2021
William Schmidt Chief Medical Officer 30 Jun 2021
Jeffrey Millard Chief Operating Officer 30 Jun 2021
Richard Wright Chief Business Officer 30 Jun 2021
Linda Pestano Chief Development Officer 04 Feb 2022
Lee Rauch Director 23 Jun 2022
Osman Nilab Chief Medical Officer 18 Apr 2022
Steven Robert Martin Director 23 Jun 2022
David Carl Humphrey Chief Financial Officer 17 Feb 2022
Adam Levin Director 23 Jun 2022
Andrew Benton Director 23 Jun 2022
Curtis Rosebraugh Director 23 Jun 2022
Kevin Geoffrey Birkett Chief Commercial Officer 17 Feb 2022

Recent Insider Transactions by Companies or Individuals for Ensysce Biosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.